Back to Directory Philip Marzinek Email marzinek@frontierscience.org Institution Frontier Science Foundation Title Laboratory Data Manager Request an Update Affiliated Studies IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in People with Hepatitis C with and without HIV DAIDS Number 39052 Research Area Therapeutics Study Status In Development
IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in People with Hepatitis C with and without HIV DAIDS Number 39052 Research Area Therapeutics Study Status In Development
